Cleared Special

K070069 - ZIPPREP ELECTRODE

K070069 is an FDA 510(k) clearance for ZIPPREP ELECTRODE, manufactured by Aspect Medical Systems, Inc.. The device is a Class 2 Neurology device with product code GXY cleared through the Special 510(k) pathway after a 28-day FDA review.

K070069 · Aspect Medical Systems, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2007
Decision
28d
Days
Class 2
Risk

K070069 is an FDA 510(k) clearance for the ZIPPREP ELECTRODE. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Aspect Medical Systems, Inc. (Norwood, US). The FDA issued a Cleared decision on February 5, 2007 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Aspect Medical Systems, Inc. devices

FDA 510(k) Submission Details - K070069

510(k) Number K070069 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 2007
Decision Date February 05, 2007
Days to Decision 28 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d faster than avg
Panel avg: 149d · This submission: 28d
Pathway characteristics
Modification to existing cleared device.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 336
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K070069.
GOLD CUP ELECTRODE, SILVER CUP ELECTRODE AND ELECTRODE WITH AG-AG/CL COATING AND CONDUCTIVE PLASTIC ELECTRODE
K071118 · Ives Eeg Solutions, Inc. · Sep 2007
CUTANEOUS ELECTROTHERAPY AND RECORDING ELECTRODES
K070807 · Pepin Mfg., Inc. · May 2007
TOP-RANK ADHESIVE ELECTRODE
K070612 · Top-Rank Health Care Equipment Co., Ltd. · May 2007
GEMORE REUSEABLE SELF ADHESIVE ELECTRODE, MODELS WIRE SERIES, SNAP SERIES AND DOUBLE SIDE SERIES
K062675 · Gemore Technology Co, Ltd. · Jan 2007
SUNSPOTS PRE-GELLED SURFACE ELECTRODES
K062198 · Axon Systems, Inc. · Dec 2006
BIS BILATERAL SENSOR
K062692 · Aspect Medical Systems, Inc. · Dec 2006